Treace Medical Concepts (TMCI) Cost of Revenue (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Cost of Revenue came in at $9.8 million in Q1 2026, down 8.3% YoY from $10.7 million in Q1 2025, and down 19.2% on a QoQ basis from $12.1 million in Q4 2025.
Treace Medical Concepts (TMCI) Cost of Revenue (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Cost of Revenue data on file, last reported at $9.8 million in Q1 2026.
- Quarterly Cost of Revenue fell 8.3% year-over-year to $9.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.1 million (up 0.98% YoY) and the FY2025 annual result came in at $42.9 million, up 4.49% from the prior year.
- Cost of Revenue eased to $9.8 million in Q1 2026, from $12.1 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $13.2 million in Q4 2024 to a low of $5.1 million in Q1 2022.
- A 5-year average of $9.1 million and a median of $9.0 million in 2022 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue surged 68.02% — and 2025, when it retreated 8.41%.
- Tracing TMCI's Cost of Revenue over 5 years: stood at $9.0 million in 2022, then gained by 27.14% to $11.5 million in 2023, then climbed by 15.36% to $13.2 million in 2024, then declined by 8.41% to $12.1 million in 2025, then declined by 19.2% to $9.8 million in 2026.
- The last three Cost of Revenue figures came in at $9.8 million (Q1 2026), $12.1 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Treace Medical Concepts | 285.57 Mn | 239.95 Mn | 35.61 Mn | 9.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.77 Mn |
| Jun 30, 2026 | 9.77 Mn |
| Mar 31, 2026 | 9.79 Mn |
| Mar 31, 2026 | 9.79 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Dec 31, 2025 | 12.12 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Jun 30, 2025 | 9.64 Mn |
| Jun 30, 2025 | 9.64 Mn |
| Mar 31, 2025 | 10.68 Mn |
| Mar 31, 2025 | 10.68 Mn |
| Dec 31, 2024 | 13.23 Mn |
| Dec 31, 2024 | 13.23 Mn |
| Sep 30, 2024 | 8.95 Mn |
| Sep 30, 2024 | 8.95 Mn |
| Jun 30, 2024 | 8.78 Mn |
| Jun 30, 2024 | 8.78 Mn |
| Mar 31, 2024 | 10.13 Mn |
| Mar 31, 2024 | 10.13 Mn |